Issue 3/2023
Special Issue: Diagnostic and Therapeutic Implications of IDH Mutations in Gliomas Following the 2021 World Health Organization Classification of CNS Tumors
Content (9 Articles)
Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Tareq A. Juratli, Christine Jungk, Julie J. Miller
Conventional and emerging treatments of astrocytomas and oligodendrogliomas
Tobias Kessler, Jakob Ito, Wolfgang Wick, Antje Wick
Glioma
Publisher's Note
Publisher’s Note
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Michael M. Wollring, Jan-Michael Werner, Garry Ceccon, Philipp Lohmann, Christian P. Filss, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
Tanja Eichkorn, Jonathan W. Lischalk, Juliane Hörner-Rieber, Maximilian Deng, Eva Meixner, Anna Krämer, Philipp Hoegen, Elisabetta Sandrini, Sebastian Regnery, Thomas Held, Semi Harrabi, Christine Jungk, Klaus Herfarth, Jürgen Debus, Laila König
Astrocytoma
Research
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center
Xianxin Qiu, Jing Gao, Jiyi Hu, Jing Yang, Weixu Hu, Qingting Huang, Haojiong Zhang, Jiade J. Lu, Lin Kong
Glioma
Review
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications
Diana D. Shi, Soummitra Anand, Kalil G. Abdullah, Samuel K. McBrayer
Glioma
Review
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology
Michael W. Parsons, David S. Sabsevitz